Ipsen Biopharmaceuticals
Ipsen Biopharmaceuticals, Inc.
106 Allen Road, 3rd Floor
Basking Ridge, NJ 07920
Phone: (908) 275-6300Website: https://www.ipsenus.com/Careers: careers.ipsen.com/na/en
Latest news
- Ipsen Receives Complete Response Letter for Palovarotene, an Investigational Treatment for Fibrodysplasia Ossificans Progressiva
23 December 2022 - Ipsen Announces U.S. FDA Priority Review for Palovarotene New Drug Application in Patients With Fibrodysplasia Ossificans Progressiva Following Resubmission
29 June 2022 - Ipsen Announces Withdrawal of Palovarotene NDA, Confirming Intention to Resubmit Following Additional Data Analyses
13 August 2021 - Ipsen Confirms U.S. FDA Accepts New Drug Application for Palovarotene as the First Potential Treatment Worldwide for Fibrodysplasia Ossificans Progressiva (FOP)
28 May 2021 - Ipsen Announces Updated Indication for Dysport (abobotulinumtoxinA) for the Treatment of Spasticity in Children
9 July 2020 - Ipsen Announces U.S. FDA Approval for Newly Designed Pre-Filled Syringe for Somatuline Depot (lanreotide)
24 June 2019 - Clementia Announces Plan to Submit a New Drug Application for Palovarotene for the Treatment of FOP Based on Positive Phase 2 Results
23 October 2018 - Clementia Initiates Phase 2 MO-Ped Trial for Palovarotene in Patients with Multiple Osteochondromas
20 April 2018 - Clementia Initiates Pivotal Phase 3 MOVE Trial for Palovarotene in Patients with Fibrodysplasia Ossificans Progressiva
12 December 2017 - FDA Approves New Indication for Ipsen’s Somatuline Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
18 September 2017
Drugs Associated with Ipsen Biopharmaceuticals, Inc.
Ipsen Biopharmaceuticals, Inc. manufactures, markets and/or distributes more than 4 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
Dysport
Generic name: abobotulinumtoxinA Drug class: skeletal muscle relaxants |
8 reviews | 5.1 / 10 |
|
Increlex
Generic name: mecasermin Drug class: insulin-like growth factors |
||
|
Onivyde
Generic name: irinotecan liposomal Drug class: miscellaneous antineoplastics |
||
|
Somatuline Depot
Generic name: lanreotide Drug class: somatostatin and somatostatin analogs |
1 review | 8.0 / 10 |
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||
